Allworth Financial’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.74M Buy
39,650
+8,845
+29% +$610K 0.01% 423
2025
Q1
$1.93M Sell
30,805
-2,594
-8% -$162K 0.01% 408
2024
Q4
$2.69M Buy
33,399
+1,897
+6% +$153K 0.01% 345
2024
Q3
$3.75M Buy
31,502
+1,062
+3% +$126K 0.02% 240
2024
Q2
$4M Buy
30,440
+1,303
+4% +$171K 0.03% 233
2024
Q1
$3.74M Buy
29,137
+13,022
+81% +$1.67M 0.03% 223
2023
Q4
$1.67M Buy
16,115
+4,504
+39% +$466K 0.01% 333
2023
Q3
$1.06M Buy
11,611
+1,979
+21% +$180K 0.01% 368
2023
Q2
$779K Buy
9,632
+4,504
+88% +$364K 0.01% 419
2023
Q1
$408K Buy
5,128
+456
+10% +$36.3K ﹤0.01% 509
2022
Q4
$316K Buy
4,672
+140
+3% +$9.47K ﹤0.01% 546
2022
Q3
$226K Buy
4,532
+3,456
+321% +$172K ﹤0.01% 567
2022
Q2
$60K Buy
1,076
+276
+35% +$15.4K ﹤0.01% 842
2022
Q1
$44K Hold
800
﹤0.01% 941
2021
Q4
$45K Hold
800
﹤0.01% 874
2021
Q3
$38K Hold
800
﹤0.01% 847
2021
Q2
$34K Buy
800
+796
+19,900% +$33.8K ﹤0.01% 713
2021
Q1
$0 Hold
4
﹤0.01% 1579
2020
Q4
$0 Hold
4
﹤0.01% 1412
2020
Q3
$0 Hold
4
﹤0.01% 1238
2020
Q2
$0 Hold
4
﹤0.01% 1315
2020
Q1
$0 Buy
+4
New ﹤0.01% 1304
2017
Q2
Sell
-162
Closed -$3K 811
2017
Q1
$3K Buy
+162
New +$3K ﹤0.01% 611